Surgery Partners, Inc. (NASDAQ:SGRY) Receives Average Rating of “Moderate Buy” from Analysts

Surgery Partners, Inc. (NASDAQ:SGRY) has been assigned an average rating of “Moderate Buy” from the six analysts that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $42.86.

Several equities analysts recently issued reports on the company. StockNews.com raised Surgery Partners from a “sell” rating to a “hold” rating in a research report on Thursday, March 21st. Benchmark restated a “buy” rating and set a $50.00 price objective on shares of Surgery Partners in a research report on Wednesday, May 1st. Barclays began coverage on Surgery Partners in a research report on Wednesday, March 6th. They set an “equal weight” rating and a $35.00 price objective for the company. Royal Bank of Canada restated an “outperform” rating and set a $49.00 price objective on shares of Surgery Partners in a research report on Thursday, February 29th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $43.00 price objective on shares of Surgery Partners in a research report on Wednesday, April 10th.

Surgery Partners Price Performance

Shares of NASDAQ SGRY opened at $24.49 on Friday. Surgery Partners has a 1 year low of $22.05 and a 1 year high of $45.79. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.71 and a quick ratio of 1.56. The company’s 50-day moving average is $25.52 and its 200 day moving average is $29.22. The stock has a market capitalization of $3.11 billion, a P/E ratio of 29.13, a P/E/G ratio of 1.90 and a beta of 2.73.

Surgery Partners (NASDAQ:SGRY) last announced its quarterly earnings results on Tuesday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.02. Surgery Partners had a net margin of 0.02% and a return on equity of 3.65%. The company had revenue of $717.40 million for the quarter, compared to analysts’ expectations of $707.66 million. On average, sell-side analysts expect that Surgery Partners will post 0.88 earnings per share for the current year.

Insider Activity at Surgery Partners

In other Surgery Partners news, insider Bradley R. Owens sold 6,000 shares of the firm’s stock in a transaction dated Friday, May 31st. The shares were sold at an average price of $27.65, for a total value of $165,900.00. Following the completion of the sale, the insider now owns 72,338 shares of the company’s stock, valued at $2,000,145.70. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 2.30% of the stock is owned by insiders.

Institutional Trading of Surgery Partners

Several institutional investors have recently added to or reduced their stakes in the company. Wellington Management Group LLP lifted its stake in Surgery Partners by 3.7% in the fourth quarter. Wellington Management Group LLP now owns 8,318,176 shares of the company’s stock worth $266,098,000 after purchasing an additional 295,476 shares during the last quarter. Vanguard Group Inc. increased its position in shares of Surgery Partners by 0.8% during the first quarter. Vanguard Group Inc. now owns 7,479,009 shares of the company’s stock worth $223,099,000 after acquiring an additional 61,400 shares during the period. Clearbridge Investments LLC increased its position in shares of Surgery Partners by 4.7% during the fourth quarter. Clearbridge Investments LLC now owns 5,525,671 shares of the company’s stock worth $176,766,000 after acquiring an additional 247,762 shares during the period. Invesco Ltd. increased its position in shares of Surgery Partners by 9.3% during the third quarter. Invesco Ltd. now owns 3,604,357 shares of the company’s stock worth $105,427,000 after acquiring an additional 305,216 shares during the period. Finally, Janus Henderson Group PLC increased its position in shares of Surgery Partners by 7,987.1% during the first quarter. Janus Henderson Group PLC now owns 2,504,248 shares of the company’s stock worth $74,701,000 after acquiring an additional 2,473,282 shares during the period.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.